Original Article
Oncogene (2007) 26, 7017–7027; doi:10.1038/sj.onc.1210507; published online 7 May 2007
Human p16
, a novel transcriptional variant of p16INK4A, coexpresses with p16INK4A in cancer cells and inhibits cell-cycle progression
Y-C Lin1,4, M B Diccianni2,4, Y Kim2, H-H Lin1, C-H Lee1, R-J Lin1, S H Joo3, J Li3, T-J Chuang1, A-S Yang1, H-H Kuo1, M-D Tsai1,3 and A L Yu1,2
- 1Genomics Research Center, Academia Sinica, Taipei, Taiwan
- 2Department of Pediatrics/Hematology-Oncology, University of California, San Diego, CA, USA
- 3Department of Chemistry, The Ohio State University, Columbus, OH, USA
Correspondence: Dr AL Yu, Genomics Research Center, Academia Sinica, 128, Academia Road, Sec. 2, Nankang Dist., Taipei 115, Taiwan. E-mail: aliceyu@ucsd.edu
4These two authors contributed equally to this work.
Received 20 December 2006; Revised 27 March 2007; Accepted 2 April 2007; Published online 7 May 2007.
Abstract
The INK4A locus encodes two tumor suppressor genes, p16INK4A and p14ARF, transcribed using alternative exons 1
or 1
spliced onto the same exons 2 and 3. Both p16INK4A and p14ARF are capable of inhibiting the cell-cycle progression, albeit in different manner; p16INK4A is phosphorylation of retinoblastoma (pRB) dependent while p14ARF is p53-dependent. In this study, we report the discovery of a novel variant of p16INK4A, termed p16
, in a primary T-cell acute lymphoblastic leukemia (T-ALL) patient sample and a neuroblastoma cell line, which was expressed at both the transcriptional and translational levels. Cloning and sequencing of the p16
cDNA revealed that p16
was identical to p16INK4A, except that it contained an in-frame insertion of 197 bp between exons 2 and 3. p16
expression was detected in the majority of p16INK4A-expressing primary T-ALL and B-ALL patient samples and other p16INK4A-expressing tumor samples, but was only barely detectable in some normal mononuclear cells and other non-tumor samples. Structural analysis by nuclear magnetic resonance and circular dichroism confirmed that p16
, like p16INK4A, is also an ankyrin-repeat protein. Functional analysis of p16
revealed that p16
protein interacted with cyclin D-dependent kinase4 and inhibited its kinase activity. Using a luciferase reporter assay, the transfection of p16
repressed the E2F response, the downstream target of pRB, with an efficacy equivalent to that of p16INK4A. Moreover p16
, like p16INK4A, induced cell-cycle arrest at G0/G1, and inhibited cell growth in colony formation assay.
Keywords:
INK4A, alternative splicing, cell-cycle inhibitor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Oncogene Original Article
Oncogene Original Article
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
Nature Article (05 Oct 2000)
Nature Genetics Article (01 Oct 1998)
